Tonix Pharmaceuticals Holding (TNXP) Current Leases (2019 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Current Leases of $162000.0 for Q1 2026, down 31.06% year-over-year from $235000.0 in Q1 2025, and up 29.6% quarter-over-quarter from $125000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Current Leases (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Current Leases history runs 8 years deep, the most recent figure standing at $162000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 31.06% year-over-year to $162000.0; the TTM figure through Mar 2026 stood at $162000.0 (down 31.06% YoY), while the FY2025 annual figure was $125000.0, down 54.38% from the prior year.
- Current Leases for Q1 2026 stood at $162000.0, up from $125000.0 in the prior quarter.
- The five-year high for Current Leases was $511000.0 in Q2 2022, with the low at $125000.0 in Q4 2025.
- The 5-year median for Current Leases is $277000.0 (2024), against an average of $317705.9.
- The sharpest annual moves came in 2023 and 2025: Current Leases gained 10.33% in 2023, then plunged 54.38% in 2025.
- Tonix Pharmaceuticals Holding's Current Leases stood at $432000.0 in 2022, then plunged by 37.5% to $270000.0 in 2023, then advanced by 1.48% to $274000.0 in 2024, then slumped by 54.38% to $125000.0 in 2025, then advanced by 29.6% to $162000.0 in 2026.
- Business Quant data shows TNXP's Current Leases at $162000.0 in Q1 2026, $125000.0 in Q4 2025, and $159000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 250,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250,000.00 |
| Mar 31, 2026 | 162,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 275,000.00 |
| Jun 30, 2024 | 277,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 434,000.00 |
| Jun 30, 2023 | 436,000.00 |
| Mar 31, 2023 | 438,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 504,000.00 |
| Jun 30, 2022 | 511,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | 489,000.00 |
| Sep 30, 2021 | 583,000.00 |